| NCT ID | NCT06377878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Preeclampsia Foundation |
| Condition | Preeclampsia |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2013-09-01 |
| Primary Completion | 2040-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2013-09-01 with a primary completion date of 2040-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medical research to try to understand why preeclampsia occurs, how to predict it better, and to develop experimental clinical trials of new treatments. The Registry will consist of a web-based survey and mechanism for collecting and reviewing medical records. This data will be utilized for immediate investigator-driven cross-sectional research projects (after proposal review by the Registry's scientific advisory board and as directed by the PI). Participants may also choose to be contacted regarding possible participation in future studies, about providing a biospecimen, as well as investigator-driven clinical trials. The Registry is anticipated to exist long-term and to serve as a foundation of participants from which to draw for studies of preeclampsia, anticipated to evolve as our scientific understanding of preeclampsia evolves.
Eligibility Criteria
Inclusion Criteria: * Women who were medically diagnosed with preeclampsia or a related hypertensive disorder of pregnancy (HDP) such as eclampsia or HELLP syndrome. * Female or Male relatives of affected women * Women who have never had preeclampsia or hypertensive disorders of pregnancy, but who would like to serve as "controls" in research studies of preeclampsia. * An authorized representative may complete the questionnaire and provide consent for a woman who had preeclampsia, but has died or is disabled as a result. Exclusion Criteria: * Those unable to provide consent * Prisoners * Individuals unable to speak English
Contact & Investigator
Eleni Z Tsigas, BA
PRINCIPAL INVESTIGATOR
Preeclampsia Foundation
Frequently Asked Questions
Who can join the NCT06377878 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying Preeclampsia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06377878 currently recruiting?
Yes, NCT06377878 is actively recruiting participants. Contact the research team at Registry@preeclampsia.org for enrollment information.
Where is the NCT06377878 trial being conducted?
This trial is being conducted at Melbourne, United States.
Who is sponsoring the NCT06377878 clinical trial?
NCT06377878 is sponsored by Preeclampsia Foundation. The principal investigator is Eleni Z Tsigas, BA at Preeclampsia Foundation. The trial plans to enroll 20,000 participants.